# Carter BloodCare – FDA Inspection, Oct 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/cfd68e9f-72fb-4a68-a7a3-23c55cb4626a
Source feed: FDA_Inspections

> FDA inspection 1070324 of Carter BloodCare, October 26, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 606, 630 and 640. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070324
- Company Name: Carter BloodCare
- Inspection Date: 2018-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1247313 - 2024-06-27
- FDA Inspection 996669 - 2016-12-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elmina-e-akwo/ecd9066d-1647-4765-ad86-dbe5280241c5)
- [FDA Associated Person](https://www.keypedia.com/people/lauren-m-lilly/41582ad0-67b1-4c60-99e2-c1e3c63811c2)
- [FDA Associated Person](https://www.keypedia.com/people/nimmy-mathews/9eac44d1-5e4c-493a-89c5-c7414a5a4037)

Company: https://www.keypedia.com/companies/carter-bloodcare/982c8b4f-590b-426e-b64d-f6e63894ddb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d